Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Gossamer Bio Inc (GOSS) just unveiled an announcement.
Gossamer Bio, Inc. has bolstered its Board of Directors by appointing two new members—Skye Drynan, with a rich background in bio-pharma and fashion, and Dr. Steven Nathan, a seasoned medical director and professor. Both bring a wealth of experience to their roles, with Drynan’s impressive tenure in healthcare investment and Nathan’s extensive medical expertise. They will receive compensation and stock options as part of the company’s non-employee director program and have been deemed independent directors, aligning with Nasdaq’s listing requirements. The appointments reflect the company’s commitment to leadership diversity and strategic growth.
See more insights into GOSS stock on TipRanks’ Stock Analysis page.